InSphero is a leading provider of industrial-grade, 3D-cell-based assay solutions and scaffold-free 3D organ-on-a-chip technology. The company partners with pharmaceutical and biotechnology researchers to accurately recreate human physiology in vitro, helping them make informed decisions. InSphero’s 3D InSight™ human tissue platforms are widely used by major pharmaceutical companies to improve efficiency in drug discovery and safety testing. The company specializes in liver toxicology, metabolic diseases, and oncology, with a focus on immuno-oncology and PDX models. The scalable Akura™ technology underlying the company’s 3D InSight™ Discovery and Safety Platforms includes 96 and 384-well plate formats and the Akura™ Flow organ-on-a-chip system, which facilitates efficient innovation throughout the drug development process.